DNA mismatch repair defects cause increased spontaneous mutation and predispose mammals to cancers such as hereditary non-polyposis colorectal cancer and lymphomas (1) (2) (3) (4) . Alkylating agents are naturally present in the environment and are also used in chemotherapeutic treatment of cancers. DNA damage produced by alkylating agents causes both spontaneous and induced mutations (5) (6) (7) (8) (9) (10) (11) . Cells have DNA repair pathways for the repair of modified DNA bases induced by alkylating agents (12) . The modified base C^-methylguanine (C^MeG*) is one of the lesions introduced into DNA after treatment with methylating agents such as A^-methyl-A^'-nitro-Af'-nitrosoguanidine (MNNG). This lesion is repaired by DNA repair methyltransferases (MTases), which remove the methyl group from the O 6 position of guanine. The C^MeG DNA lesion is mutagenic because it can base pair with thymine, causing GC-»AT transition mutations. However, C^MeG is also capable of pairing with cytosine, in which case no mutation results (13) . In addition to being mutagenic, C^MeG is cytotoxic in both prokaryotic and eukaryotic cells (8, (14) (15) (16) (17) (18) (19) , but the mechanism by which this lesion causes cell death is not fully understood. Two lines of evidence suggest that processing of C^MeG by the DNA mismatch repair system may cause cell death. Jones and Wagner (20) and Karran and Marinus (21) reported that Escherichia coli dam~ strains, which are proficient © Oxford University Press in post-replication DNA mismatch repair but deficient in strand discrimination, showed a marked sensitivity to killing by MNNG but not by dimethyl sulfate (DMS). The major difference between these alkylating agents is that MNNG induces significantly higher levels of C^MeG in DNA than does DMS (22, 23) . The hypersensitivity of danr cells to MNNG was suppressed by mutations in either mutS or mutL, which inactivate the DNA mismatch repair pathway. These observations led Karran and Marinus (21) to suggest that the cytotoxicity of C^MeG DNA lesions may be mediated by interaction of the post-replication DNA mismatch repair system with C^MeG sites on DNA. Such an interaction of DNA mismatch repair with alkylation damage was proposed to occur upon replication of DNA containing C^MeG; the insertion of either C or T opposite the C^MeG (the only two bases that efficiently pair with C^MeG) (24, 25) would result in repeated futile rounds of DNA mismatch repair. It is thought that repeated excision and reincorporation of nucleotides opposite C^MeG produces persistent DNA breaks that ultimately cause cell death.
The Mer~ phenotype of human cells is characterized by a sensitivity to alkylating agents caused by the absence of the DNA repair MTase (MGMT) that repairs C^MeG (14, 15, 17, (26) (27) (28) . Alkylation-resistant Mer cell lines have been isolated which are able to tolerate C^MeG lesions in the DNA (29) (30) (31) and several of these alkylation-resistant Mer derivatives turn out to be deficient in DNA mismatch repair. For example, the alkylation-resistant MT1 cell line carries a mutation in the gene encoding pi60 (GTBP), a homolog of the E.coli MutS protein. The human proteins pl60 and hMSH2 (another MutS homolog) form a heterodimer thought to bind mismatched bases and loops of 1-3 unpaired bases in DNA (32) (33) (34) . To test whedier DNA mismatch repair systems can act upon an C^MeG-containing DNA template we have studied the interaction of the E.coli MutS DNA mismatch repair recognition protein with this lesion in vitro. Band shift analysis was used to assess binding of the MutS protein to oligonucleotides containing various modified bases. We find that MutS specifically binds to oligonucleotide duplexes containing C^MeG lesions but fails to bind oligonucleotides with other base modifications, namely (7*-methylthymine ((7*MeT) and 8-oxoguanine (8oxoG).
The oligonucleotides used in this study are shown in Figure  1 . To prepare labeled oligonucleotide duplexes the unmodified strands were labeled with T4 polynucleotide kinase and [y- reaction volume did not exceed 10 JJ.1. After incubation for 30 min at 0°C, 50% (w/v) sucrose solution was added to a final concentration of 36%. The protein-DNA complexes were resolved by electrophoresis through a 5% non-denaturing polyacrylamide gel at 4°C and then visualized by autoradiography. MutS protein formed a specific complex with the oligonucleotide duplex containing an C^MeGiC base pair ( Figure  2A ). Note that we did not include oligonucleotides containing C^MeGiT base pairs in this study, because it is well established that MutS efficiently binds G:T base pairs and a demonstration that MutS binds C^MeGiT base pairs would not demonstrate any specificity for alkylated DNA. As a positive control for the binding activity of the MutS protein, we used a substrate previously shown to have a high affinity for MutS binding, namely a heteroduplex containing one unpaired base (1 bp loop) (35) . Purified MutS protein not only bound the 1 bp loop heteroduplex ( Figure 2B and C) , but also bound the C^MeG-containing duplex. Competition binding assays demonstrated that the binding of MutS to the C^MeG-containing substrate was specific (Figure 2A ). Both the unlabeled C^MeG-containing duplex and the 1 bp loop heteroduplex effectively inhibited MutS binding to the labeled C^MeG-containing duplex. In contrast, control homoduplex, containing perfectly complementary bases, failed to inhibit such binding. Moreover, pre-incubation of the C^MeG-containing oligonucleotide with either the E.coU Ada MTase or the human MGMT MTase (for repair of C^MeG) diminished subsequent MutS binding (data not shown).
MutS is known to bind and initiate repair at base pairs containing the guanine analogs inosine and 7-deazainosine (36, 37) . To define further the specificity of MutS binding we used an oligonucleotide duplex containing an 8oxoG:C base pair in the gel-retardation assay. Figure 2B shows that while MutS efficiently bound the labeled C^MeG and 1 bp loop substrates, it did not bind the labeled control homoduplexes (as expected) nor did it bind the substrate containing an 8oxoG:C base pair, at least in this sequence context.
MTase-deficient cell lines that are resistant to alkylating agents can tolerate methylating agents such as MNNG and Nmethyl-A'-nitrosourea (29, 30) , which introduce both C^MeG and C^MeT lesions into DNA. Both of these DNA lesions are substrates for repair by MTases (38) (39) (40) . In contrast to the specific binding of bacterial MutS to templates containing (^MeG (Figure 2A and B) , we found that MutS fails to bind to this oligonucleotide duplex containing (7*MeT ( Figure 2C) .
The level of MTase activity varies between species and the level in human tissues is in general higher than that in mice and rats. Within a species there is also a marked tissue-specific variation in MTase activity (41) ; the liver expresses the highest activity, followed by intestine, lung, T lymphocytes, colon and brain. One might predict that tissues with low MTase activity are more prone to mutagenic damage as a result of higher accumulation of C^MeG in their genomes, from both endogenous alkylation and from exposure to exogenous alkylating agents. However, it is tempting to speculate that a cellular mechanism exists whereby unrepaired C^MeG DNA lesions may trigger cell death rather than persisting as potentially mutagenic lesions in the genome. This lethality could conceivably occur through the DNA mismatch repair system initiating an arbortive repair process at replicated C^MeG DNA lesions. This would lead to persistent DNA strand breaks in the vicinity of the lesion, resulting in cell death (20, 21) . This model is consistent with the recent finding that in the absence of MTase activity, a mouse cell line deficient in the DNA mismatch repair protein MSH2 (a homolog of bacterial MutS) tolerates higher doses of the alkylating agent MNNG than does the isogenic MSH2-proficient cell line (4). Indeed, Karran et al. (42) showed that CfiMeG.C DNA lesions elicit DNA repair synthesis in vitro and, since processing of this lesion was not mediated by the nucleotide excision repair pathway, that it was likely due to the DNA mismatch repair pathway. Our results provide biochemical evidence that a DNA mismatch recognition protein, in this case the E.coli MutS protein, has a specific affinity for the potentially mutagenic lesion C^MeG. It remains to be shown whether any of the mammalian DNA mismatch recognition proteins (MutS homologs) specifically recognize C^MeG and whether binding of MutS homologs to C^MeG is indeed capable of initiating the mismatch repair process, leading to an accumulation of persistent DNA strand breaks. Such demonstrations would validate the proposal that in both prokaryotes and eukaryotes, the DNA mismatch repair system can reduce the accumulation of mutant cells by turning potentially mutagenic lesions into cytotoxic lesions.
